| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8316903 | Clinical Biochemistry | 2018 | 35 Pages |
Abstract
Assessment of miRNAs in serum samples can be applied as minimally non-invasive markers for early detection of breast cancer, and as discriminator between different clinicopathological characters.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Menha Swellam, Hekmat M. El Magdoub, Naglaa M. Hassan, Mona M. Hefny, Mohamed Emam Sobeih,